Low doses of genistein (4′,5,7-trihydroxyisoflavone) for 48 h are able to reverse the EMT process in prostate cancer cell lines LNCaP, LNCaP/HIF-1a, and IA8-ARCaP, as demonstrated by the cell morphological features and the upregulation of the E-cadherin together with the loss of expression of vimentin [77]. This evidence concerns the gene VIM and prostate carcinoma.